Compare Caprion Pharmaceuticals vs Lead Therapeutics
Customers evaluate the quality of Caprion Pharmaceuticals's products using the following success metrics.
Overview
Caprion Pharmaceuticals is 26 yrs old and is based in Canada.
Caprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk and enhance clinical development productivity and decision making in Pharmaceutical research. In March 2007, Caprion Pharmaceuticals merged with Ecopia BioSciences to form Thallion Pharmaceuticals.
Lead Therapeutics is 18 yrs old and is based in United States.
LEAD Therapeutics, Inc. is a chemistry-driven drug discovery company focused on delivering novel and differentiated small molecule pre-IND candidates against clinically validated therapeutic targets by leveraging the best of the US and China. Headquartered in the San Francisco Bay Area, LEAD Therapeutics is led by an experienced small molecule drug discovery team with proven track records in the pharmaceutical and biotech industries. The company plans to carry out the majority of its discovery research activities in China.
Demo Video
Leadership
Clarissa Desjardins (Founder)
Leonard Post (Founder)
Investors
Thallion Pharmaceuticals, Ventures West
Pappas Ventures, ProQuest Investments
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Caprion Pharmaceuticals has not claimed their profile.
Work for Caprion Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Caprion Pharmaceuticals?
Claim your profile now.
Information not available because Lead Therapeutics has not claimed their profile.
Work for Lead Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Lead Therapeutics?
Claim your profile now.